Showing items 1–100
Chromium containing compositions for improving health and fitness
Grant US-11865121-B2
United States of America
Chromium containing compositions for improving health and fitness
Grant US-11857553-B2
United States of America
Growth differentiation factor 15 as biomarker for metformin
Grant US-11807905-B2
United States of America
METHOD FOR DETERMINING INSULIN DOSAGE
Application WO-2023194615-A1
World Intellectual Property Organisation (WIPO)
SiRNA, medical compositions, and methods for treating type ii diabetes using the same
Grant US-11746350-B2
United States of America
Combination therapy for the treatment of diabetes
Grant US-11576894-B2
United States of America
Insufflation apparatus and methods
Grant US-11446127-B2
United States of America
Red blood cell dynamics for gastrointestinal evaluation
Grant US-11319571-B2
United States of America
White blood cell population dynamics
Grant US-11293852-B2
United States of America
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and…
Grant US-11207337-B2
United States of America
Growth differentiation factor 15 as biomarker for metformin
Grant US-10975434-B2
United States of America
Methods of estimating blood glucose and related systems
Grant US-10955423-B2
United States of America
Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with…
Grant US-10828308-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-10751488-B2
United States of America
Interactive apparatus and method for real-time profiling of inhalation efforts
Grant US-10675421-B2
United States of America
Blister package for pharmaceutical cartridges
Grant US-10625034-B2
United States of America
Pharmaceutical formulations
Grant US-10617668-B2
United States of America
Mouthpiece cover for an inhaler
Grant US-10561806-B2
United States of America
Process for the preparation of compounds useful as inhibitors of SGLT2
Grant US-10544135-B2
United States of America
Treatment type 2 diabetes mellitus patients
Grant US-10434147-B2
United States of America
Microcrystalline diketopiperazine compositions and methods
Grant US-10421729-B2
United States of America
Dry powder drug delivery system
Grant US-10342938-B2
United States of America
Use of ultrarapid acting insulin
Grant US-10307464-B2
United States of America
Methods and compositions for treating pain
Grant US-10258664-B2
United States of America
Methods and compositions for the sustained release of chromium
Grant US-10245325-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-10201672-B2
United States of America
METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
Application EP-3427746-A1
European Patent Office
Substituted diketopiperazine analogs for use as drug delivery agents
Grant US-10172850-B2
United States of America
Inhalable vaccine compositions and methods
Grant US-10159644-B2
United States of America
Treatment of type 2 diabetes mellitus patients
Grant US-10159713-B2
United States of America
Method of drug formulation
Grant US-10143655-B2
United States of America
Diketopiperazine salts for drug delivery and related methods
Grant US-10130685-B2
United States of America
High capacity diketopiperazine microparticles and methods
Grant US-10130709-B2
United States of America
Method for improving the pharmaceutic properties of microparticles comprising…
Grant US-10130581-B2
United States of America
Combination of an insulin and a GLP-1 agonist
Grant US-10117909-B2
United States of America
Use of ultrarapid acting insulin
Grant US-10046031-B2
United States of America
Pharmaceutical composition comprising a GLP-1-agonist and methionine
Grant US-10028910-B2
United States of America
Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
Grant US-10029011-B2
United States of America
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
Grant US-9987332-B2
United States of America
Use of AVE0010 for the treatment of diabetes mellitus type 2
Grant US-9981013-B2
United States of America
Apparatus, system and method for measuring resistance of an inhaler
Grant US-9983108-B2
United States of America
Insulin glargine/lixisenatide fixed ratio formulation
Grant US-9950039-B2
United States of America
Use of ultrarapid acting insulin
Grant US-9943571-B2
United States of America
Heat-stable dry powder pharmaceutical compositions and methods
Grant US-9925144-B2
United States of America
Methods and compositions for treatment of metabolic disorders
Grant US-9907848-B2
United States of America
METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
Application EP-3251686-A1
European Patent Office
Pharmaceutical combination for improving glycemic control as add-on therapy to basal…
Grant US-9821032-B2
United States of America
Dry powder drug delivery system and methods
Grant US-9802012-B2
United States of America
Potentiation of glucose elimination
Grant US-9801925-B2
United States of America
Catalysis of diketopiperazine synthesis
Grant US-9796688-B2
United States of America
DRUG COMBINATIONS AND METHODS TO STIMULATE EMBRYONIC-LIKE REGENERATION TO TREAT DIABETES…
Application WO-2017142952-A1
World Intellectual Property Organisation (WIPO)
USE OF ULTRARAPID ACTING INSULIN
Application EP-3207942-A1
European Patent Office
Method of drug formulation based on increasing the affinity of crystalline microparticle…
Grant US-9717689-B2
United States of America
Apparatus and method for simulating inhalation efforts
Grant US-9706944-B2
United States of America
Inhalation apparatus
Grant US-9700690-B2
United States of America
Diketopiperazine salts for drug delivery and related methods
Grant US-9675674-B2
United States of America
Dry powder drug delivery system and methods
Grant US-9662461-B2
United States of America
Substituted diketopiperazine analogs for use as drug delivery agents
Grant US-9655850-B2
United States of America
Diketopiperazine microparticles with defined specific surface areas
Grant US-9630930-B2
United States of America
Method to screen for an activator of adipose-resident NK cells
Grant US-9623083-B2
United States of America
Methods and compositions for treating pain
Grant US-9610351-B2
United States of America
Use of ultrarapid acting insulin
Grant US-9597374-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-9511198-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-9446133-B2
United States of America
Increasing drug affinity for crystalline microparticle surfaces
Grant US-9446001-B2
United States of America
METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
Application EP-3067061-A1
European Patent Office
High capacity diketopiperazine microparticles and methods
Grant US-9364436-B2
United States of America
Interactive apparatus and method for real-time profiling of inhalation efforts
Grant US-9364619-B2
United States of America
Catalysis of diketopiperazine synthesis
Grant US-9346766-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-9339615-B2
United States of America
Method for improving the pharmaceutic properties of microparticles comprising…
Grant US-9241903-B2
United States of America
Methods and compositions for treating pain
Grant US-9233159-B2
United States of America
Substituted diketopiperazine analogs for use as drug delivery agents
Grant US-9220687-B2
United States of America
Dry powder inhaler and system for drug delivery
Grant US-9192675-B2
United States of America
Process for the preparation of compounds useful as inhibitors of SGLT2
Grant US-9174971-B2
United States of America
Method of treating a patient
Application US-9061153-B1
United States of America
Process for the preparation of compounds useful as inhibitors of SGLT
Grant US-9056850-B2
United States of America
L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiop…
Grant US-9035044-B2
United States of America
Process for the preparation of compounds useful as inhibitors of SGLT
Grant US-9024009-B2
United States of America
Potentiation of glucose elimination
Grant US-9006175-B2
United States of America
Method for insulin resistance improving and a method for prevention or treatment of…
Grant US-8916521-B2
United States of America
Methods and compositions for delivering peptides
Grant US-8889099-B2
United States of America
Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
Grant US-8853385-B2
United States of America
Glucopyranoside compound
Grant US-8785403-B2
United States of America
Method and composition for treating migraines
Grant US-8785396-B2
United States of America
Crystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienyl…
Grant US-8772512-B2
United States of America
DETERMINATION OF A TENDENCY TO GAIN WEIGHT
Application WO-2014060542-A1
World Intellectual Property Organisation (WIPO)
Method of treating diabetes type 2 by administering ultrarapid acting insulin
Grant US-8623817-B2
United States of America
Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]b…
Grant US-8513202-B2
United States of America
Diagnosis and complication risk assessment of pancreatic diabetes within normal value…
Application EP-2626704-A1
European Patent Office
Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects
Grant US-8501686-B2
United States of America
Screening method for an insulin resistance improving agent or a therapeutic agent for…
Grant US-8492105-B2
United States of America
Reducing risk of type 2 diabetes (T2D)
Grant US-8445467-B2
United States of America
Compounds having an isolated peptide consisting of structure (I)
Grant US-8354373-B2
United States of America
Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin…
Grant US-8258095-B2
United States of America
Glucopyranoside compound
Grant US-8222219-B2
United States of America
SINGLE NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH RISK OF INSULIN RESISTANCE DEVELOPMENT
Application WO-2012080816-A2
World Intellectual Property Organisation (WIPO)
Glucopyranoside compound
Grant US-8202984-B2
United States of America
METHODS FOR DETECTING LOW GRADE INFLAMMATION
Application WO-2012069511-A1
World Intellectual Property Organisation (WIPO)
Showing items 1–100